Holen Sie sich die Stockscreener-App
7.83
24.35%
-2.52
Handel nachbörslich:
8.08
0.25
+3.19%
Schlusskurs vom Vortag:
$10.35
Offen:
$9
24-Stunden-Volumen:
127.13K
Relative Volume:
6.03
Marktkapitalisierung:
$41.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-71.07M
KGV:
-15.98
EPS:
-0.49
Netto-Cashflow:
$-63.98M
1W Leistung:
-11.82%
1M Leistung:
-3.21%
6M Leistung:
-45.55%
1J Leistung:
+50.29%
1-Tages-Spanne:
$7.68
$9.74
1-Wochen-Bereich:
$7.68
$10.50
52-Wochen-Spanne:
$5.00
$19.00
Vicarious Surgical Inc Stock (RBOT) Company Profile
Firmenname
Vicarious Surgical Inc
Sektor
Branche
Telefon
(617) 868-1700
Adresse
78 FOURTH AVENUE, WALTHAM
Vergleichen Sie RBOT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
7.83 | 54.58M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Eingeleitet | Credit Suisse | Outperform |
| 2021-12-07 | Eingeleitet | Cowen | Outperform |
| 2021-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-10-18 | Eingeleitet | BTIG Research | Buy |
| 2021-10-07 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Vicarious Surgical Inc Aktie (RBOT) Neueste Nachrichten
Vicarious Surgical delays robot timeline - MedTech Dive
What institutional flow reveals about Vicarious Surgical Inc.2025 Stock Rankings & Real-Time Volume Triggers - Newser
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use By Investing.com - Investing.com South Africa
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use - Investing.com Australia
Trend analysis for Vicarious Surgical Inc. this weekTrade Volume Report & Free Technical Confirmation Trade Alerts - Newser
Tools to monitor Vicarious Surgical Inc. Equity Warrant recovery probabilityMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Will Vicarious Surgical Inc. rebound enough to break evenJuly 2025 Movers & Daily Oversold Bounce Ideas - Newser
Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript - Insider Monkey
Earnings visualization tools for Vicarious Surgical Inc.2025 AllTime Highs & Reliable Intraday Trade Alerts - Newser
Live market analysis of Vicarious Surgical Inc.July 2025 Macro Moves & Low Risk Entry Point Guides - Newser
Tick level data insight on Vicarious Surgical Inc. volatilityMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Combining price and volume data for Vicarious Surgical Inc. Equity Warrant2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Is Vicarious Surgical Inc. Equity Warrant forming a bottoming baseRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Vicarious Surgical Narrows Loss in Q2 - AOL.com
Can Vicarious Surgical Inc. Equity Warrant recover in the next quarterProfit Target & Fast Gaining Stock Strategy Reports - Newser
Published on: 2025-08-13 09:06:39 - beatles.ru
Published on: 2025-08-13 01:02:27 - Newser
Will Vicarious Surgical Inc. Equity Warrant outperform the marketEarnings Growth Report & Real-Time Volume Analysis - Newser
Vicarious Surgical Reports Improved Q2 Financials and Leadership Change - TipRanks
Will a bounce in Vicarious Surgical Inc. Equity Warrant offer an exitNew Guidance & Expert Approved Momentum Trade Ideas - Newser
Vicarious Surgical's Q2 2025: Unraveling Contradictions in Clinical Trials, System Readiness, and Supply Chain Stability - AInvest
Vicarious Surgical Narrows Loss in Q2 - The Motley Fool
What MACD and RSI say about Vicarious Surgical Inc.Short-Term Trade Setup with Forecast Insight - Newser
Vicarious Surgical outlines new CEO transition and strategic shift to production system readiness amid $50M cash burn target - MSN
Vicarious Surgical Inc. stock volume spike explainedLong Hold Investment Strategy with Growth Focus - Newser
Vicarious Surgical appoints new CEO; co-founder Adam Sachs to remain as president - MSN
Statistical indicators supporting Vicarious Surgical Inc.’s strength [Earnings Summary Report]Low Drawdown Investment Ideas - Newser
Price momentum metrics for Vicarious Surgical Inc. Equity Warrant explained [Market Risk Analysis] - Newser
Earnings call transcript: Vicarious Surgical’s Q2 2025 results show cost efficiency - Investing.com
Transcript : Vicarious Surgical Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Surgical Robotics Pioneer Vicarious Cuts Losses 13% as New CEO Takes Helm - Stock Titan
Vicarious Surgical Reports Second Quarter 2025 Financial Results - Bluefield Daily Telegraph
Real time social sentiment graph for Vicarious Surgical Inc.Free Price Action Based Buy Opportunity List - Newser
Why Vicarious Surgical Inc. Equity Warrant stock attracts strong analyst attentionFree Entry Alert With Low Drawdown Strategy - Newser
How sentiment analysis helps forecast Vicarious Surgical Inc.Smart Entry Signals for Active Traders - Newser
What analysts say about Vicarious Surgical Inc. Equity Warrant stock outlookReal-Time Signal Tracking with Entry Level - Newser
Why Vicarious Surgical Inc. stock attracts strong analyst attentionAccurate Forecast System with AI Support - Newser
SEC Filings Archive 2025-08-11Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Moving Average Crossover Confirms Uptrend in Vicarious Surgical Inc.Accurate Technical Trend Reversal Picks Detected - metal.it
What does recent volatility data suggest for Vicarious Surgical Inc.Free Beginner Friendly Stock Selection Guide - Newser
Is this a good reentry point in Vicarious Surgical Inc. Equity WarrantFree Low Drawdown Real Time Trading Tips - Newser
How Vicarious Surgical Inc. stock performs during market volatilityFree Low Risk Equity Screener With Results - Newser
Using economic indicators to assess Vicarious Surgical Inc. potentialDaily Market Momentum and Pressure Analysis - Newser
Does Vicarious Surgical Inc. fit your quant trading modelFree Investment Plan With Growth Optimization - Newser
Trend Dashboard Flags Vicarious Surgical Inc. As Potential Swing TradeConservative Long Term Growth Plans Under Review - beatles.ru
Finanzdaten der Vicarious Surgical Inc-Aktie (RBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):